1Steen VD. Pregnancy in scleroderma[J]. Rheum Dis Clin North Am, 2007, 33(2): 345-358.
2Gayed M, Gordon C. Pregnancy and rheumatic diseases[J]. Rheumatology (Oxford), 2007, 46( 11 ) : 1634-1640.
3Burrows RF, Burrows EA. Assessing the teratogenic potential of angiotensin-converting enzyme inhibitors in pregnancy [J]. Aust N Z J Obstet Gynaecol, 1998, 38(3) : 306-311.
4Diav-Citrin O, Amon J, Shechtman S, et al. The safety of proton pump inhibitors in pregnancy: a muhicentre prospective controlled study[J]. Aliment Pharrnacol Ther, 2005, 21 (3) : 269-275.
5Berthelot JM, De Bandt M, Goupille P, et al. Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature[J]. Joint Bone Spine, 2009, 76( 1 ) : 28-34.
